1. Home
  2. SOPA vs TOVX Comparison

SOPA vs TOVX Comparison

Compare SOPA & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Society Pass Incorporated

SOPA

Society Pass Incorporated

SELL

Current Price

$3.14

Market Cap

6.5M

Sector

Technology

ML Signal

SELL

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.25

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPA
TOVX
Founded
2018
2001
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.3M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
SOPA
TOVX
Price
$3.14
$0.25
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$22.50
N/A
AVG Volume (30 Days)
13.6M
10.6M
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,227,427.00
N/A
Revenue This Year
$26.32
N/A
Revenue Next Year
$13.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.65
N/A
52 Week Low
$0.64
$0.17
52 Week High
$6.75
$2.03

Technical Indicators

Market Signals
Indicator
SOPA
TOVX
Relative Strength Index (RSI) 61.94 55.44
Support Level $2.41 $0.19
Resistance Level $4.46 $0.26
Average True Range (ATR) 0.67 0.03
MACD 0.21 0.01
Stochastic Oscillator 61.03 84.25

Price Performance

Historical Comparison
SOPA
TOVX

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: